Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
N/A
-300,103 Closed
0 $0
Q1 2021

May 17, 2021

SELL
N/A
-102,224 Reduced 25.41%
300,103 $6.27 Million
Q4 2020

Feb 16, 2021

BUY
N/A
19,683 Added 5.14%
402,327 $0
Q3 2020

Nov 16, 2020

BUY
N/A
142,847 Added 59.57%
382,644 $6.24 Million
Q2 2020

Aug 14, 2020

SELL
N/A
-40,578 Reduced 14.47%
239,797 $3.25 Million
Q1 2020

May 15, 2020

BUY
N/A
105,989 Added 60.78%
280,375 $3.32 Million
Q4 2019

Feb 14, 2020

BUY
N/A
152,025 Added 679.87%
174,386 $4.34 Million
Q3 2019

Nov 14, 2019

BUY
N/A
22,361 New
22,361 $380,000
Q2 2019

Aug 14, 2019

SELL
N/A
-146,267 Closed
0 $0
Q1 2019

May 15, 2019

BUY
N/A
137,280 Added 1527.54%
146,267 $4.7 Million
Q4 2018

Feb 14, 2019

BUY
N/A
8,987 New
8,987 $253,000
Q2 2018

Aug 14, 2018

SELL
N/A
-182,158 Closed
0 $0
Q1 2018

May 15, 2018

BUY
N/A
182,158 New
182,158 $7.16 Million

About Intersect ENT, Inc.


  • Ticker XENT
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,461,700
  • Market Cap $945M
More about XENT
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.